Neurology-neuroimmunology & Neuroinflammation

SCI SCIE

国际简称：NEUROL-NEUROIMMUNOL 参考译名：神经病学-神经免疫学和神经炎症

主要研究方向：Neuroscience-Neurology 非预警期刊审稿周期：8 Weeks

《神经病学-神经免疫学和神经炎症》(Neurology-neuroimmunology & Neuroinflammation)是一本由Lippincott Williams and Wilkins Ltd.出版的以Neuroscience-Neurology为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本开放期刊，近三年没有被列入预警名单。该期刊享有很高的科学声誉，影响因子不断增加，发行量也同样高。

1区中科院分区
Q1 JCR分区
111 年发文量
8 IF影响因子
开放是否OA
2014 创刊年份
6 issues/year 出版周期
English 出版语言

Neurology: Neuroimmunology & NeuroInflammation is an official journal of the American Academy of Neurology.

Vision: Our vision is to be the premier peer-reviewed journal for experts in the fields of neuroimmunology and neuroinflammation.

Mission: The mission of Neurology Neuroimmunology & Neuroinflammation is to provide neurologists and translationally minded scientists with peer-reviewed articles, editorials, and reviews to enhance patient care, education, and clinical & translational research.

We publish rigorously peer-reviewed open access reports of original research and in-depth reviews of topics in neuroimmunology & neuroinflammation, affecting the full range of neurologic diseases including (but not limited to): Alzheimer disease, Parkinson disease, ALS, tauopathy, and stroke; multiple sclerosis and NMO; inflammatory peripheral nerve and muscle disease, Guillain-Barré and myasthenia; nervous system infection; paraneoplastic syndromes, noninfectious encephalitides and other antibody-mediated disorders; and psychiatric and neurodevelopmental disorders. Clinical trials, instructive case reports, and small case series will also be featured.

[ 查看全部 ]

投稿咨询加急咨询

Neurology-neuroimmunology & Neuroinflammation期刊信息

ISSN：2332-7812
出版语言：English
是否OA：开放
E-ISSN：2332-7812
出版地区：United States
是否预警：否
出版商：Lippincott Williams and Wilkins Ltd.
出版周期：6 issues/year
创刊时间：2014
开源占比：0.9901
Gold OA文章占比：100.00%
OA被引用占比：1
出版国人文章占比：0.01
出版撤稿占比：0
研究类文章占比：92.79%

Neurology-neuroimmunology & Neuroinflammation CiteScore评价数据（2026年6月最新版）

CiteScore

SJR

SNIP

CiteScore 指数

13.3

2.4

1.942

学科类别	分区	排名	百分位
大类：Neuroscience 小类：Neurology	Q1	7 / 201	96%
大类：Neuroscience 小类：Neurology (clinical)	Q1	18 / 403	95%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Neurology-neuroimmunology & Neuroinflammation中科院评价数据

《新锐期刊分区表》（2026年3月发布）

Top期刊	综述期刊	大类学科		小类学科
是	否	医学	1区	CLINICAL NEUROLOGY 临床神经病学 NEUROSCIENCES 神经科学	1区 1区

Neurology-neuroimmunology & Neuroinflammation JCR评价数据

2025-2026年最新版

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：CLINICAL NEUROLOGY	SCIE	Q1	17 / 296	94.4
学科：NEUROSCIENCES	SCIE	Q1	27 / 330	92
学科：CLINICAL NEUROLOGY	SCIE	Q1	12 / 296	96.11
学科：NEUROSCIENCES	SCIE	Q1	14 / 330	95.91

Neurology-neuroimmunology & Neuroinflammation历年数据统计

影响因子

中科院分区

Neurology-neuroimmunology & Neuroinflammation中国学者发文选摘

1、Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum Disorde
Author: Mahler, Joao Vitor; Vallejos, Gerome B.; Mikami, Takahisa; Bilodeau, Philippe A.; Anderson, Monique; Drosu, Natalia; Bobrowski-Khoury, Natasha; Silva, Guilherme Diogo; Solti, Marina; Apostolos-Pereira, Samira Luisa; Callegaro, Dagoberto; Leles Vieira De Souza, Bruna; Manzano, Giovanna Sophia; Vishnevetsky, Anastasia; Gillani, Rebecca; Pasquale, Olivia; Kim, Angie; Vij, Raveena; Kister, Ilya; Gibbons, Emily L.; Jacob, Anu; Huda, Saif; Said, Yana; Krett, Jonathan D.; Sotirchos, Elias S.; Ramprasad, Manisha; Abboud, Hesham; Crelier, Viviane Tavares Carvalho; Dos Santos, Gutemberg; Uawithya, Ekdanai; Siritho, Sasitorn; Sezen, Ahmetcan; Altintas, Ayse; Gai, Feng; Guo, Yanjun; Bhattacharyya, Shamik; Levy, Michael; Matiello, Marcelo

Journal: NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION. 2026; Vol. 13, Issue 2, pp. -. DOI: 10.1212/NXI.0000000000200514
2、Complement Inhibition for Acute Neuromyelitis Optica Spectrum Disorder Attack
Author: Rommer, Paulus S.; Jiang, Wei; Nolte, Jan P.; Mikami, Takahisa; De Seze, Jerome; Sanchez, Pedro; Harel, Asaff; Alkabie, Samir; Kaneko, Kimihiko; Bilodeau, Philippe A.; Misu, Tatsuro; Kremer, Laurent; Bigaut, Kevin; Leypoldt, Frank; Aktas, Orhan; Ringelstein, Marius; Siffrin, Volker; Zhang, Lin-Jie; Cong, Hengri; Lowe, Mallory; Barreras, Paula; Chen, Haiwen; Piquet, Amanda L.; Sotirchos, Elias S.; Kammeyer, Ryan; Zook, Jadyn; Bennett, Jeffrey L.; Berger, Thomas; Fujihara, Kazuo; Levy, Michael; Shi, Fu-Dong; Paul, Friedemann

Journal: NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION. 2026; Vol. 13, Issue 2, pp. -. DOI: 10.1212/NXI.0000000000200548
3、Complement C5 Inhibitor Ameliorates a Case of Dysferlinopath
Author: Kang, Shuaikun; Wang, Qingqing; Lv, He; Deng, Jianwen; Zhang, Wei; Lu, Xin; Yuan, Yun; Wang, Zhaoxia; Zheng, Fuze; Yu, Meng

Journal: NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION. 2026; Vol. 13, Issue 2, pp. -. DOI: 10.1212/NXI.0000000000200539
4、Clinical and Paraclinical Characterizations, Management, and Prognosis in DPPX Antibody-Associated Encephaliti
Author: Li, Er-Chuang; Zhang, Tian-Yi; Cai, Meng-Ting; Su, Sheng-Yao; Shen, Chun-Hong; Lai, Qi-Lun; Zhang, Yin-Xi

Journal: NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION. 2025; Vol. 12, Issue 2, pp. -. DOI: 10.1212/NXI.0000000000200350